Business

Oppenheimer initiates Evommune stock rating at Outperform, $50 target

Apr 7, 2026 - 14:00
 0
Oppenheimer initiates Evommune stock rating at Outperform, $50 target
Read More

Related Posts

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025  3

London's Heathrow Airport to reopen after fire causes power outage

London's Heathrow Airport to reopen after fire causes p...

Mar 21, 2025  8

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  10

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0

DOGE says IRS modernization program is $15B over budget and 30 years overdue

DOGE says IRS modernization program is $15B over budget...

Mar 21, 2025  2

Elon Musk says DOGE cuts necessary, but face headwinds according to Fox poll

Elon Musk says DOGE cuts necessary, but face headwinds ...

Mar 21, 2025  2